GLORIA EGBUNIWE: Open Payments
NPI 1912572009 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 16 payments from 5 companies in 2025. Trend: 2023 $709 · 2024 $412 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $207 |
| ABBVIE INC. | 5 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, CAPLYTA, Qelbree, Auvelity.
Industry payments across VA — which companies pay providers there.
